Srinivas Akkaraju
Board Member
Kalaris Therapeutics, Inc. (KLRS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Srinivas Akkaraju
Srinivas Akkaraju is recorded as Board Member at Kalaris Therapeutics, Inc. (KLRS). Kalaris Therapeutics, Inc. reported in an 8-K filed March 18, 2025 that Srinivas Akkaraju was appointed Board, effective March 18, 2025.
“Andrew Oxtoby, Srinivas Akkaraju, M.D., Ph.D. and Samir Patel, M.D. were appointed as Class II directors”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-03-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kalaris Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew Oxtoby CEO, Board Member
- Diana M. Brainard CEO, Board Member
- Vikas Sinha CEO
- David Hallal Chairman, Board Member
- Brett Hagen CFO
- Liisa Bayko CFO
- Matthew Gall CFO
- Amy Vandekop Chief Accounting Officer
- Anthony Adamis Board Member
- Derek Adams, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.